Unlocking the potential of novel hybrid lipid polymer nanoparticles in redefining camptothecin delivery: Achieving controlled release, enhanced cytotoxicity, and improved pharmacokinetics for colorectal cancer therapy
- 27 January 2025
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 105
Abstract
No abstract availableKeywords
Funding Information
- Charotar University of Science and Technology (RP1/21)
This publication has 41 references indexed in Scilit:
- Potential of injectable psoralen polymeric lipid nanoparticles for cancer therapeuticsArabian Journal of Chemistry, 2024
- Nanotechnology and Cancer Bioelectricity: Bridging the Gap Between Biology and Translational MedicineAdvanced Science, 2023
- Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluationDrug Delivery and Translational Research, 2023
- A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatmentActa Biomaterialia, 2022
- Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA deliveryBiomaterials, 2014
- pH‐Dependent Anticancer Drug Release from Silk NanoparticlesAdvanced Healthcare Materials, 2013
- Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug releaseActa Biomaterialia, 2013
- Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticlesColloids and Surfaces B: Biointerfaces, 2011
- PLGA–lecithin–PEG core–shell nanoparticles for controlled drug deliveryBiomaterials, 2009
- The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)–tocopheryl polyethylene glycol succinate nanoparticlesBiomaterials, 2006